Current oncology reports

Curr Oncol Rep · ISSN (e) 1534-6269 · 6 papers in corpus
review 2024
doi:10.1007/s11912-024-01595-6 ·PMID:39361077

PURPOSE OF REVIEW: This review aims to describe the association of integrating traditional Chinese medicine (TCM) herbs into conventional medicine (CM) in preventing breast cancer and improving survival rates among breast cancer patients of…

review 2024
doi:10.1007/s11912-024-01603-9 ·PMID:39361076

PURPOSE OF REVIEW: This review aims to synthesize available literature on uterine-conserving treatment options for atypical endometrial hyperplasia and grade 1 endometrial carcinoma while highlighting remaining unanswered questions. RECENT…

review 2023
doi:10.1007/s11912-022-01352-7 ·PMID:36696075

PURPOSE OF REVIEW: Head and neck tumors (HNC) rank sixth among cancers worldwide. Due to their late diagnosis and poor prognosis, they are a clinical challenge. However, recent years have seen a dynamic development of science on the microbi…

review 2019
doi:10.1007/s11912-019-0816-0 ·PMID:31346778

PURPOSE OF REVIEW: Both conventional and novel approaches to early detection of ovarian cancer are reviewed in the context of new developments in our understanding of ovarian cancer biology. RECENT FINDINGS: While CA125 as a single value l…

review 2016
doi:10.1007/s11912-016-0552-7 ·PMID:27718181

Adenosarcomas are rare malignancies of the female genital tract, accounting for approximately 5 % of uterine sarcomas. Occasionally, adenosarcoma occurs in the ovaries or in extra-uterine tissue, which may be related to endometriosis. These…

review 2013
doi:10.1007/s11912-013-0346-0 ·PMID:24114188

Clear cell carcinomas of the female genital tract are rare tumours with a fearsome reputation for having poor responses to conventional platinum-based chemotherapy and poor prognosis. However, it is now clear that early-stage ovarian clear …